{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-027034","form_type":"8-K","ticker":"BACK","cik":"0001729944","company_name":"IMAC Holdings, Inc.","filed_at":"2025-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.825439+00:00","generated_at":"2026-05-17T07:02:24.991745+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ignite Proteomics (BACK) enters $420K biomarker study with Inova for GI cancers","bullets":["Subsidiary Ignite Proteomics will analyze up to 600 tumor samples using RPPA technology.","Maximum contract value $420,000; $175,000 payable upon execution.","Data on 32+ protein biomarkers including HER2, RET, MHC-II, EGFR, TROP2, AKT, ERK.","Results provided to Inova's Molecular Tumor Board to guide late-stage gastrointestinal cancer therapy.","Agreement expected to contribute meaningfully to Ignite's 2025 revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-027034","json":"https://secwatch.observer/filing/0001641172-25-027034.json","markdown":"https://secwatch.observer/filing/0001641172-25-027034.md","text":"https://secwatch.observer/filing/0001641172-25-027034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729944/000164117225027034/0001641172-25-027034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729944/000164117225027034/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:02:24.991745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}